Auxiliary TARP Subunits Define AMPA Receptor Pharmacology and Function

Area of Science:

• Neuroscience
• Pharmacology

Background:

• AMPA-type glutamate receptors mediate fast excitatory neurotransmission in the central nervous system.
• Dysregulation of AMPA receptor function is linked to neuronal hyperexcitability and epilepsy.
• Modulating AMPA receptor gating kinetics, particularly in a TARP-dependent and subunit-specific manner, is a potential therapeutic strategy.

Purpose of the Study:

• To characterize the effects of novel dibenzobarrelene-based heterocycles on AMPA receptor function.
• To investigate the mechanism of action, including effects on gating kinetics and dependence on auxiliary subunits.
• To establish a pharmacological framework for developing new epilepsy therapies.

Main Methods:

• Whole-cell patch-clamp electrophysiology was used to record currents from cells expressing GluA1 or GluA1/2 AMPA receptors.
• Cells were co-expressed with the TARPγ8 auxiliary subunit to assess its influence.
• The effects of eight dibenzobarrelene derivatives on glutamate-induced currents, desensitization, and deactivation were measured.

Main Results:

• All tested compounds suppressed glutamate-induced currents, acting as negative allosteric modulators.
• The compounds accelerated AMPA receptor desensitization and deactivation kinetics.
• Co-expression of TARPγ8 partially reduced the inhibitory and kinetic effects of the compounds, but did not abolish them.

Conclusions:

• Dibenzobarrelene derivatives impair AMPA receptor function through a specific kinetic mechanism.
• These compounds reduce agonist-bound open states and promote transitions to non-conducting states.
• The findings provide mechanistic insights into AMPA receptor modulation and its dependence on auxiliary proteins.